Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients

Published:2018-06 Issue:6 Volume:38 Page:620-627
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Varga Alexandra N.¹,Johnson David¹,Sawinski Deirdre L.²,Lim Mary Ann²,Bloom Roy D.²,Abt Peter L.³,Goral Simin²,Bleicher Melissa²,Levine Matthew H.³,Naji Ali³,Nazarian Susanna³,Porrett Paige³,Trofe-Clark Jennifer¹²^ORCID

Affiliation:

1. Department of Pharmacy Services; Hospital of the University of Pennsylvania; Philadelphia Pennsylvania

2. Renal Electrolyte and Hypertension Division; Department of Medicine; Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania

3. Division of Transplant Surgery; Department of Surgery; Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania

Publisher

Wiley

Subject

Pharmacology (medical)

Reference22 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients;Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group;Am J Transplant,2009

2. Alemtuzumab induction in renal transplantation;Hanaway;N Engl J Med,2011

3. Efficacy and safety of antibody induction therapy in the current era of kidney transplantation;Opelz;Nephrol Dial Transplant,2016

4. Rabbit antithymocyte globulin versus basiliximab in renal transplantation;Brennan;N Engl J Med,2006

5. Interleukin 2 receptor antagonists for kidney transplant recipients;Webster;Cochrane Database Syst Rev,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A call for transplant stewardship: The need for expanded evidence‐based evaluation of induction and biologic‐based cost‐saving strategies in kidney transplantation and beyond;Clinical Transplantation;2021-06-08

2. Single‐center, real‐world experience with granulocyte colony‐stimulating factor for management of leukopenia following kidney transplantation;Clinical Transplantation;2019-04-11